Viemed Healthcare
VMD
41 hedge funds and large institutions have $80.7M invested in Viemed Healthcare in 2019 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 6 closing their positions.
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
30% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 10
17% more funds holding
Funds holding: 35 → 41 (+6)
1.45% more ownership
Funds ownership: 32.45% → 33.9% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less capital invested
Capital invested by funds: $84.7M → $80.7M (-$4.04M)
Top Buyers
Top Sellers
VMD Hedge Fund Activity: Q4 2019 in Review
41 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q4 2019, worth a combined $80.7M — down 4.8% from $84.7M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new VMD positions and 6 closed out — a net gain of 7 holders — while 13 added to existing stakes and 10 trimmed.
The largest buyer was Hillsdale Investment Management, adding an estimated $2.47M. The largest seller was EAM Global Investors, exiting entirely with an estimated $2.55M sold.
- 41 institutional investors held Viemed Healthcare (VMD) as of Q4 2019, up from 35 in Q3 2019.
- Funds reported $80.7M of Viemed Healthcare stock for Q4 2019, down 4.8% quarter-over-quarter.
- 13 funds opened new Viemed Healthcare positions in Q4 2019 and 6 closed out, a net change of +7 holders.
- The largest Viemed Healthcare buyer in Q4 2019 was Hillsdale Investment Management, an estimated $2.47M added.
- The largest Viemed Healthcare seller in Q4 2019 was EAM Global Investors, an estimated $2.55M sold.
Based on aggregated 13F filings for Q4 2019.